Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: A historic cohort study

BMC Nephrology

Volumn 11, Issue 1, 2010, Pages

  Del Fabbro, Patrizia ^a   Luthi, Jean Christophe ^b,c   Carrera, Emmanuel ^a   Michel, Patrik ^a   Burnier, Michel ^a   Burnand, Bernard ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Health Observatory   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; STROKE; SURVIVAL TIME; CHRONIC DISEASE; COMORBIDITY; KIDNEY DISEASE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANEMIA; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 77957926553     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-11-27     Document Type: Article

References (43)

1. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the ARIC cohort. WD Rosamond AR Folsom LE Chambless,, et al. Stroke 1999 30 736 743 10187871
2. Statistics about stroke. Cureresearch.com. http://www.cureresearch.com/s/ stroke/prevalence.htm
3. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. GJ Hankey CP Warlow, Lancet 1999 354 1457 63 10.1016/S0140-6736(99)04407-4 10543686
4. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. SG Wannamethee AG Shaper IJ Perry, Stroke 1997 28 557 563 9056611
5. Elevated risk of stroke among patients with end-stage renal disease. SL Seliger DL Gillen WT Longstreth,, et al. Kidney Int 2003 64 603 609 10.1046/j.1523-1755.2003.00101.x 12846756
6. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study. JL Abramson CT Jurkovitz V Vaccarino,, et al. Kidney Int 2003 64 610 615 10.1046/j.1523-1755.2003.00109.x 12846757
7. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AS Levey J Coresh E Balk,, et al. Ann Intern Med 2003 139 137 147 12859163
8. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. RD Langston R Presley WD Flanders,, et al. Kidney Int 2003 64 1398 1405 10.1046/j.1523-1755.2003.00200.x 12969159
9. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. RMA Henry PJ Kostense G Bos,, et al. Kidney Int 2002 62 1402 1407 10.1111/j.1523-1755.2002.kid571.x 12234312
10. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. CT Jurkovitz JL Abramson LV Vaccarino,, et al. J Am Soc Nephrol 2003 14 2919 2925 10.1097/01.ASN.0000092138.65211.71 14569102
11. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: An analysis of shared risk factors. P Muntner J Coresh MJ Klag,, et al. Am J Kidney Dis 2002 40 323 330 10.1053/ajkd.2002.34515 12148105
12. Serum creatinine: an independent predictor of survival after stroke. PJ Friedman, J Intern Med 1991 229 175 179 10.1111/j.1365-2796.1991.tb00327.x 1997642
13. The Lausanne Stroke Registry: Analysis of 1,000 Consecutive Patients With First Stroke. J Bogousslavsky G Van Melle F Regli, Stroke 1988 19 1083 1092 3413804
14. Follow-up report on the diagnosis of diabetes mellitus. S Genuth KG Alberti P Bennett,, et al. Diabetes Care 2003 26 11 3160 3167 10.2337/diacare.26.11.3160 14578255
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 17 106 3143 421
16. World Health Organization, Indicators and Strategies for Iron Deficiency and Anemia Programmes. Report of the WHO/UNICEF/UNU Consultation., 6-10 December 1993;Geneva, Switzerland 1994
17. K/DOQIclinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 1 266 10.1016/S0272-6386(02)70081-4 11904577
18. Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. R Botev JP Mallié, et al. Clin J Am Soc Nephrol 2009 4 899 906 10.2215/CJN.05371008 19406960
19. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. H Quan V Sundararajan P Halfon,, et al. Medical Care 2005 43 1130 1139 10.1097/01.mlr.0000182534.19832.83 16224307
20. Survival Analysis. A Self-learning Text. DG Kleinbaum, New York, USA: Springer-Verlag 1997
21. The Impact of Confounder Selection Criteria on Effect Estimation. RM Mickey S Greenland, Am J Epidemiol 1989 129 125 137 2910056 (Pubitemid 19030705)
22. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. WM McClellan WD Flanders RD Langston,, et al. J Am Soc Nephrol 2002 13 1928 1936 10.1097/01.ASN.0000018409.45834.FA 12089390
23. Anemia and Chronic kidney disease are associated with poor outcomes in heart failure patients. JC Luthi WD Flanders M Burnier,, et al. BMC Nephrol 2006 7 3 10.1186/1471-2369-7-3 16515712
24. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. A Al-Ahmad WM Rand G Manjunath,, et al. J Am Coll Cardiol 2001 38 955 962 10.1016/S0735-1097(01)01470-X 11583864
25. Acute myocardial infarction and renal dysfunction: A high-risk combination. RS Wright GS Reeder CA Herzog,, et al. Ann Intern Med 2002 137 563 570 12353943
26. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: Results from the Cooperative Cardiovascular Project Among Patients With Renal Insufficiency. HM Krumholz J Chen YT Chen,, et al. Kidney Int 2001 60 292 299 10.1046/j.1523-1755.2001.00799.x 11422764
27. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. CY Hsu CE McCulloch GC Curhan, J Am Soc Nephrol 2002 13 504 510 10.1097/01.ASN.0000034200.82278.DC 11805181
28. What are the short-term and long-term consequences of anaemia in CRF patients? JF Mann, Nephrol Dial Transplant 1999 14 Suppl 2 29 36 10.1093/ndt/14.suppl-2.29 10334665
29. Serum creatinine levels as a prognostic factor of survival in elderly patients hospitalized with acute stroke. AD Efstratopoulos SM Voyaki MA Meikopoulos, Cerebrovasc Dis 2005 19 suppl 2 1 159
30. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. AJ Erslev A Besarab, Kidney Int 1997 51 622 630 10.1038/ki.1997.91 9067892
31. Recombinant human erythropoietin and renal anemia: Molecular biology, clinical efficacy, and nervous system effects. AR Nissenson Sd Nimer DL Wolcott, Ann Intern Med 1991 111 402 416
32. Relationship between hematocrit and renal function in men and women. CY Hsu DW Bates GJ Kuperman,, et al. Kidney Int 2001 59 725 731 10.1046/j.1523-1755.2001.059002725.x 11168955
33. An estimate of the size of the US predialysis population with renal insufficiency and anemia. MJ Strauss FK Port C Somen,, et al. Am J Kidney Dis 1993 21 264 269 8447302
34. Anemia in chronic renal disease: Lessons learned since Seville 1994. P Parfrey, Nephrol Dial Transplant 2001 16 41 45 11590256
35. Effect of anemia and cardiovascular disease on surgical mortality and morbidity. JL Carson A Duff RM Poses,, et al. Lancet 1996 348 1055 1060 10.1016/S0140-6736(96)04330-9 8874456
36. The hemodynamic response to chronic anemia. M Duke WH Abelmann, Circulation 1969 39 503 515 5778251
37. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. A Levin CR Thompson J Ethier,, et al. Am J Kidney Dis 1999 34 125 134 10.1016/S0272-6386(99)70118-6 10401026
38. Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: A collaborative study among research centres in Europe. ML Bots Y Nikitin JT Salonen,, et al. J Epidemiol Community Health 2002 56 8 13 10.1136/jech.56.suppl-1.i8 11801614
39. Insights into oxidative stress and atherosclerosis. JC Tardif, Can J Cardiol 2000 16 2D 4D 10932028
40. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. RS Mac Walter SYS Wong KYK Wong,, et al. Stroke 2002 33 1630 1635 10.1161/01.STR.0000016344.49819.F7 12053003
41. Impact of Aortic Stiffness on survival in end-stage renal disease. J Blacher AP Guerin B Pannier,, et al. Circulation 1999 99 2434 2439 10318666
42. In vivo evidence that erythropoietin protects neurons from ischemic damage. M Sakanaka TC Wen S Maatsuda,, et al. Proc Natl Acad Sci USA 1998 95 4635 4640 10.1073/pnas.95.8.4635 9539790
43. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. MA Pfeffer EA Burdmann Chao-Yin Chen, , et al. N Engl J Med 2009 361 2019 32 10.1056/NEJMoa0907845 19880844